Citrus Life Sciences Private Limited
About Citrus Life Sciences Private Limited
Data last updated:
Citrus Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 29 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U15139DL2004PTC125502. Its GSTIN is 07AACCC3513H1Z2 (Delhi).
The company has an authorised share capital of ₹1.28 Cr and a paid-up capital of ₹1.28 Cr. It is led by directors Renu Adawal and Shanker Adawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 369 2nd Floor Block D Defence Colony, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.76 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹76.52 Lakh (net margin 43.5%) and EBITDA of ₹90.04 Lakh (EBITDA margin 51.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Citrus Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address369 2nd Floor Block D Defence Colony, New Delhi, Delhi, India – 110024
- IndustryLife Sciences, Biotechnology
To see the full contact details of Citrus Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Citrus Life Sciences is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Citrus Life Sciences Private Limited, buy the company report.
Financials of Citrus Life Sciences Private Limited
FY 2025 filings availableCitrus Life Sciences Private Limited reported revenue of ₹1.76 Cr (down 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 3% fall in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 51.2% | ||||
| Net Profit Margin | 43.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Citrus Life Sciences Private Limited, buy the company report.
Board of directors of Citrus Life Sciences Private Limited
Citrus Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Adawal | Director | 29 Mar 2004 | 22 Years 7 Months | Current |
| Shanker Adawal | Director | 29 Mar 2004 | 22 Years 7 Months | Current |
Auditor
Citrus Life Sciences Private Limited is audited by ANISH ASHISH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANISH ASHISH & CO | FY 2020 | 002535N |
Shareholding
The shareholding of Citrus Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Citrus Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Citrus Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Citrus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Citrus Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCC3513H1Z2 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Citrus Life Sciences Private Limited, buy the company report.
Recent activity
Citrus Life Sciences Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Renu Adawal ceased to be Managing Director on 30 Sep 2019.
Frequently asked questions
Citrus Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 29 March 2004 (22+ years old) and is registered under CIN U15139DL2004PTC125502.
Citrus Life Sciences has 2 current directors:
- Renu Adawal - Director
- Shanker Adawal - Director
The latest financial statements of Citrus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Citrus Life Sciences is 07AACCC3513H1Z2, registered in Delhi.
The CIN (Corporate Identification Number) of Citrus Life Sciences is U15139DL2004PTC125502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Citrus Life Sciences was incorporated on 29 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Renu Adawal ceased to be Managing Director on 30 Sep 2019. Renu Adawal was appointed as Director on 29 Mar 2004. Shanker Adawal was appointed as Director on 29 Mar 2004.
The registered office of Citrus Life Sciences is at 369 2nd Floor Block D Defence Colony, New Delhi, Delhi, India – 110024.
Citrus Life Sciences operates in the life sciences industry, in the biotechnology segment.
The compliance status of Citrus Life Sciences is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
